About Acme Generics LLP
Data last updated:
Acme Generics LLP was a limited liability partnership (LLP) based in Chandigarh, India. The LLP has been converted into a company and no longer exists as an LLP. For the latest details, refer to the successor company. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 March 2015.
The LLP was registered with the Registrar of Companies (ROC), Chandigarh, under LLPIN AAD-5392. Its GSTIN is 02ABCFA2649A1Z9 (Himachal Pradesh). The LLP held 2 GST registrations, all of them active.
The LLP had a total obligation of contribution of ₹113.94 Cr. It was led by designated partners Ruby Shah and Viral Shah.
Its latest statement of accounts is for the year ended 31 March 2021. The registered office was at Plot No – 75 Industrial Area Phase – 1, Chandigarh, India – 160002.
As per the financials filed for FY 2021, the LLP reported a revenue of ₹264.12 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹19.51 Cr (net margin 7.4%) and EBITDA of ₹43.84 Cr (EBITDA margin 16.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 51% over five years.
The LLP is associated with 1 brand: Acme Generics. As per MCA filings, the LLP has satisfied charges of ₹15 Cr on record.
The last known website on record is acmegenerics.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No – 75 Industrial Area Phase – 1, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Acme Generics LLP
Acme Generics operates one associated brand: Acme Generics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Solid and liquid formulations are manufactured as a CDMO focus. | acmegenerics.in |
Competitors & Alternatives of Acme Generics LLP
Brands and companies operating in the same space as Acme Generics LLP include Abzena, Syngene, Grand River Aseptic Manufacturing and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Abzena | Provider of antibody discovery, cell line development, and bio analytics services | Cambridge, United Kingdom | 2001 |
 Syngene | Provider of contract research and manufacturing services for both small molecules and biologics | Bengaluru, India | 1993 |
 Grand River Aseptic Manufacturing | Sterile parenteral CDMO services for development and manufacturing are offered. | Grand Rapids, United States | 2010 |
 Patheon | Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | Durham, United States | 1974 |
 Panacea Biotec | Developer of biosimilars, vaccines and natural products | Ambala, India | 1984 |
 Piramal Group | Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | Mumbai, India | 1984 |
 Maravai Life Sciences | Provides enabling tools and services in the life sciences research and bio-production industries | San Diego, United States | 2014 |
 LakePharma | Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | Belmont, United States | 2009 |
 Insud Pharma | Finished formulations, APIs, and monoclonal antibodies are developed and manufactured. | Madrid, Spain | 1977 |
Auditor Details of Acme Generics LLP
Acme Generics LLP is audited by VINOD KUMAR & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VINOD KUMAR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Designated Partners of Acme Generics LLP
Acme Generics has 2 current designated partners and 5 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ruby Shah Also directs: Ambriel Life Sciences LLP, Tekno Touch Private Limited | Designated Partner | 01 Apr 2021 | 5 Years 6 Months | As last reported |
| Viral Shah Also directs: Ambriel Life Sciences LLP, Acme Generics Private Limited, Acme Formulation Private Limited and 4 more | Designated Partner | 01 Apr 2021 | 5 Years 6 Months | As last reported |
Financials of Acme Generics LLP FY 2021 filings available
Acme Generics LLP reported revenue of ₹264.12 Cr (up 13% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Acme Generics LLP
Revenue has grown at a compounded annual rate (CAGR) of 51% over five years, including 13% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Acme Generics LLP
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | ₹264.12 Cr | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹19.51 Cr | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Acme Generics LLP
| Statement of Account and Solvency | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 7.4% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Acme Generics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Acme Generics LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Acme Generics LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Dec 2018 | Hdfc Bank Limited | ₹15 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Acme Generics LLP
Employment history and EPFO contributions of people linked to Acme Generics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Acme Generics LLP
Acme Generics has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02ABCFA2649A1Z9 | Himachal Pradesh | Active | 01 Jul 2017 |
| 29ABCFA2649A1ZT | Karnataka | Active | 01 Jul 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Acme Generics LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Acme Generics LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acme Generics LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acme Generics LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Acme Generics LLP
Frequently Asked Questions about Acme Generics LLP
Acme Generics has been converted into a company - the business changed its legal structure from a Limited Liability Partnership to a company. The LLP no longer exists in its previous form. For the latest information, refer to the successor company registered with MCA.
Acme Generics was a limited liability partnership based in Chandigarh, India. The LLP worked in drug formulation and development, within the pharma industry. It was incorporated on 13 March 2015 and is registered under LLPIN AAD-5392. For the latest details, refer to the successor company.
The LLPIN (Limited Liability Partnership Identification Number) of Acme Generics is AAD-5392. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Acme Generics had 2 designated partners:
- Ruby Shah - Designated Partner
- Viral Shah - Designated Partner
Acme Generics was incorporated on 13 March 2015. It is registered with the Registrar of Companies, Chandigarh.
Acme Generics can be reached through the website acmegenerics.in. Its registered office is in Chandigarh, India.
The registered office of Acme Generics is at Plot No – 75 Industrial Area Phase – 1, Chandigarh, India – 160002.
Acme Generics reported revenue of ₹264.12 Cr for FY 2021 (up 13% YoY).
The total obligation of contribution is ₹113.94 Cr.